Seshadri Neervannan

Title: Seshadri Neervannan: Innovator in Pharmaceutical Formulations

Introduction

Seshadri Neervannan is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 3 patents. His work focuses on improving the stability and efficacy of injectable formulations, particularly in the context of irritant agents.

Latest Patents

Neervannan's latest patents include innovative formulations that enhance the safety and effectiveness of medical treatments. One of his key inventions is related to stable emulsion formulations, which are designed to provide injectable formulations of irritant agents, such as calcimimetics. These formulations are pharmaceutically stable and aim to reduce the incidence of irritation, pain, phlebitis, precipitation, and hemolysis upon injection. Another significant patent involves hydrate forms of AMG706, an anti-angiogenic drug. This invention provides AMG 706 in the mono-phosphate hydrate form and includes processes for preparing the drug substance, as well as a method for treating medical conditions where anti-angiogenic treatment is indicated.

Career Highlights

Throughout his career, Seshadri Neervannan has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug formulation.

Collaborations

Neervannan has collaborated with several professionals in his field, including Gonzalo Alva and Anuradha V Gore. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Seshadri Neervannan is a distinguished inventor whose work in pharmaceutical formulations has led to significant advancements in the field. His innovative patents reflect his commitment to improving medical treatments and enhancing patient safety.